ACE2 and viral infectious disease: Khanna et al. [13] found that multiple thiol drugs inhibit SARS-CoV-2 binding to ACE2 and virus entry into cells, whereas the intraperitoneal injection of cysteamine to hamsters infected with SARS-CoV-2 decreased inflammation in the lungs but failed to decrease viral infection.